Cancel
See Linkedin
Robert Hess is a board member, angel investor, and patent attorney with a focus on pharmaceuticals, medtech, and B2B SaaS. He is a member of several angel groups and serves as co-chair of the Digital Health committee at Life Science Angels.
Robert Hess's Title
Robert Hess serves as a Board Member and is highly respected in various professional circles for his multifaceted expertise. His roles encompass strategic advising, angel investing, and legal counsel, particularly in the realms of pharmaceuticals, medtech, and B2B SaaS. His board membership and advisory roles leverage his extensive background in both scientific and legal domains, making him a valuable asset to the organizations he is involved with.
Robert Hess's Education and Expertise
Robert Hess holds a B.S. in Biochemistry from Cornell University, a Ph.D. in Molecular Biophysics from the University of Wisconsin – Madison, and a J.D. from Suffolk University Law School. His diverse educational background equips him with a deep understanding of both the scientific and legal aspects of the biotechnology and medical device industries. This unique combination of expertise allows him to navigate complex regulatory environments and contribute to the advancement of innovative technologies.
Robert Hess's Background
Robert Hess has a rich professional background that includes roles at prominent organizations such as Solazyme, Boston Biomedica, BioSeq, Sunstein Kann Murphy & Timbers, Biomarin Pharmaceutical, and Leydig, Voit & Mayer. His experience spans both in-house and private practice positions as a patent attorney, where he has successfully prosecuted patents in the biotechnology and medical device sectors. This extensive experience has made him a trusted advisor and a key player in the life sciences and technology industries.
Robert Hess's Achievements
Robert Hess is a distinguished member of several angel investment groups, including the Life Science Angels (LSA), Band of Angels, and Tech Coast Angels. He serves as co-chair of the Digital Health committee at the Life Science Angels, where he plays a pivotal role in guiding investments and strategic initiatives in the digital health sector. His contributions to the field have been instrumental in driving innovation and supporting the growth of early-stage companies in the life sciences and technology industries.
Report inaccurate information
